Company intelligence / Profile preview
Aquestive Therapeutics
Warren, New Jersey, United Statesaquestive.com ↗
- Ownership
- Public · AQST
- Employees
- ~175
- Development stage
- Commercial
01
Overview
Aquestive has completed pivotal Phase III studies for Anaphylm™ (epinephrine sublingual film) showing comparable or faster absorption than leading autoinjectors. NDA submission to FDA expected Q1 2025; pediatric data in line with expectations. Five products are already commercialized through licensees, including Sympazan® oral film for Lennox-Gastaut Syndrome[3][7][10].
- Therapeutic areas
- DermatologyImmunologyNeurology
- Modalities
- Oral film drug delivery (PharmFilm® technology)Topical gel formulations
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Collaborates with pharmaceutical companies to bring new molecules to market using PharmFilm®, but specific partners not listed in current results[4][6].Licensees market its products globally.
04
Financials
- Market cap
- $459.4M
- Total revenue
- $44.5M
- Enterprise value
- $377.1M
Beyond the preview
Go deeper on Aquestive Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aquestive Therapeutics.